Author:
Mehta Rashmi,Green Michelle,Patel Bela,Wagg Jonathan
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Global Initiative for Chronic Obstructive Lung Disease (2015) Global strategy for the diagnosis, management, and prevention of COPD. www.goldcopd.org . Accessed 9 March 2015
2. Cazzola M, Centanni S, Santus P, Verga M, Mondoni M, di Marco F, Matera MG (2004) The functional impact of adding salmeterol and tiotropium in patients with stable COPD. Respir Med 98:1214–1221
3. Cazzola M, Noschese P, Salzillo A, De Giglio C, D’Amato G, Matera MG (2005) Bronchodilator response to formoterol after regular tiotropium or to tiotropium after regular formoterol in COPD patients. Respir Med 99:524–528
4. van Noord JA, Aumann JL, Janssens E, Smeets JJ, Verhaert J, Disse B, Mueller A, Cornelissen PJ (2005) Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD. Eur Respir J 26:214–222
5. van Noord JA, Aumann JL, Janssens E, Verhaert J, Smeets JJ, Mueller A, Cornelissen PJ (2006) Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD. Chest 129:509–517
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献